转移性前列腺癌-话题@MedSci

#转移性前列腺癌#

60篇内容 | 1218人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2150343, encodeId=aaed2150343f9, content=<a href='/topic/show?id=7bbf93405a5' target=_blank style='color:#2F92EE;'>#转移性前列腺癌#</a> , objectTitle=转移性前列腺癌, objectType=topic, longId=93405, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=23, createdTime=2023-07-29, rootId=0, userName=498997979, userId=edcf4883751, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=江苏省, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2150126, encodeId=a468215012653, content=<a href='/topic/show?id=7bbf93405a5' target=_blank style='color:#2F92EE;'>#转移性前列腺癌#</a> 学习了, objectTitle=转移性前列腺癌, objectType=topic, longId=93405, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=25, createdTime=2023-07-27, rootId=0, userName=498997979, userId=edcf4883751, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=江苏省, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395568, encodeId=f2cb1395568fb, content=<a href='/topic/show?id=7bbf93405a5' target=_blank style='color:#2F92EE;'>#转移性前列腺癌#</a>, objectTitle=Eur Urol Oncol：雄激素剥夺疗法联合根治性局部治疗与单独的雄激素剥夺疗法治疗新诊断寡转移性前列腺癌的疗效比较 , objectType=article, longId=732585, objectId=c18be325856d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c18be325856d, replyNumber=0, likeNumber=41, createdTime=2022-07-18, rootId=0, userName=ms24272190615788285182, userId=4e842500199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c18be325856d, moduleTitle=Eur Urol Oncol：雄激素剥夺疗法联合根治性局部治疗与单独的雄激素剥夺疗法治疗新诊断寡转移性前列腺癌的疗效比较 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c18be325856d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395567, encodeId=2c42139556e82, content=<a href='/topic/show?id=7bbf93405a5' target=_blank style='color:#2F92EE;'>#转移性前列腺癌#</a>, objectTitle=NEJM Evid：奥拉帕利联合阿比特龙治疗转移性前列腺癌结果公布（PROpel研究）, objectType=article, longId=729571, objectId=1e09e2957129, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e09e2957129, replyNumber=0, likeNumber=46, createdTime=2022-06-16, rootId=0, userName=ms24272190615788285182, userId=4e842500199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e09e2957129, moduleTitle=NEJM Evid：奥拉帕利联合阿比特龙治疗转移性前列腺癌结果公布（PROpel研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e09e2957129)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395566, encodeId=c97b13955667c, content=<a href='/topic/show?id=7bbf93405a5' target=_blank style='color:#2F92EE;'>#转移性前列腺癌#</a>, objectTitle=Eur Urol：非转移性前列腺癌患者中，高强度聚焦超声局部治疗后的癌症控制结果 , objectType=article, longId=299087, objectId=d12e29908ecd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d12e29908ecd, replyNumber=0, likeNumber=49, createdTime=2022-02-19, rootId=0, userName=ms24272190615788285182, userId=4e842500199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d12e29908ecd, moduleTitle=Eur Urol：非转移性前列腺癌患者中，高强度聚焦超声局部治疗后的癌症控制结果 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d12e29908ecd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395565, encodeId=b6391395565b7, content=<a href='/topic/show?id=7bbf93405a5' target=_blank style='color:#2F92EE;'>#转移性前列腺癌#</a>, objectTitle=BJU Int：根治性前列腺切除术治疗寡转移性前列腺癌的可行性和安全性评估 , objectType=article, longId=294256, objectId=f8c32942566b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8c32942566b, replyNumber=0, likeNumber=35, createdTime=2022-01-20, rootId=0, userName=ms24272190615788285182, userId=4e842500199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8c32942566b, moduleTitle=BJU Int：根治性前列腺切除术治疗寡转移性前列腺癌的可行性和安全性评估 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8c32942566b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395564, encodeId=05f213955640b, content=<a href='/topic/show?id=7bbf93405a5' target=_blank style='color:#2F92EE;'>#转移性前列腺癌#</a>, objectTitle=Front Oncol：化疗对转移性前列腺癌患者的总生存期影响, objectType=article, longId=221253, objectId=76b2221253f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76b2221253f9, replyNumber=0, likeNumber=59, createdTime=2021-12-01, rootId=0, userName=ms24272190615788285182, userId=4e842500199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76b2221253f9, moduleTitle=Front Oncol：化疗对转移性前列腺癌患者的总生存期影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76b2221253f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395563, encodeId=578913955631b, content=<a href='/topic/show?id=7bbf93405a5' target=_blank style='color:#2F92EE;'>#转移性前列腺癌#</a>, objectTitle=Front Oncol：基于SEER数据库比较前列腺癌根治术（PR）和放疗（RT）治疗转移性前列腺癌的生存结果, objectType=article, longId=221181, objectId=8b0d221181c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b0d221181c4, replyNumber=0, likeNumber=42, createdTime=2021-11-29, rootId=0, userName=ms24272190615788285182, userId=4e842500199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b0d221181c4, moduleTitle=Front Oncol：基于SEER数据库比较前列腺癌根治术（PR）和放疗（RT）治疗转移性前列腺癌的生存结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b0d221181c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395562, encodeId=ec2c139556275, content=<a href='/topic/show?id=7bbf93405a5' target=_blank style='color:#2F92EE;'>#转移性前列腺癌#</a>, objectTitle=Lynparza联合阿比特龙治疗转移性前列腺癌，疗效积极, objectType=article, longId=217701, objectId=9f5221e7016c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f5221e7016c, replyNumber=0, likeNumber=36, createdTime=2021-09-28, rootId=0, userName=ms24272190615788285182, userId=4e842500199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f5221e7016c, moduleTitle=Lynparza联合阿比特龙治疗转移性前列腺癌，疗效积极, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f5221e7016c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395561, encodeId=c3c213955614c, content=<a href='/topic/show?id=7bbf93405a5' target=_blank style='color:#2F92EE;'>#转移性前列腺癌#</a>, objectTitle=J Clin Oncol：前瞻性评估液体活检技术在针对不同耐药机制的转移性前列腺癌的临床预后作用, objectType=article, longId=213684, objectId=7049213684cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7049213684cd, replyNumber=0, likeNumber=36, createdTime=2021-07-05, rootId=0, userName=ms24272190615788285182, userId=4e842500199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7049213684cd, moduleTitle=J Clin Oncol：前瞻性评估液体活检技术在针对不同耐药机制的转移性前列腺癌的临床预后作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7049213684cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395560, encodeId=abae1395560cd, content=<a href='/topic/show?id=7bbf93405a5' target=_blank style='color:#2F92EE;'>#转移性前列腺癌#</a>, objectTitle=Eur Urol Focus：非转移性前列腺癌根治术后尿失禁的患者和肿瘤相关预后因素分析 , objectType=article, longId=211755, objectId=1f0d211e555f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f0d211e555f, replyNumber=0, likeNumber=37, createdTime=2021-05-26, rootId=0, userName=ms24272190615788285182, userId=4e842500199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f0d211e555f, moduleTitle=Eur Urol Focus：非转移性前列腺癌根治术后尿失禁的患者和肿瘤相关预后因素分析 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f0d211e555f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395559, encodeId=40ef13955593e, content=<a href='/topic/show?id=7bbf93405a5' target=_blank style='color:#2F92EE;'>#转移性前列腺癌#</a>, objectTitle=JNCCN: 循环肿瘤DNA（ctDNA）应用于去势抵抗的转移性前列腺癌临床管理：多中心真实世界研究结果, objectType=article, longId=211442, objectId=1e5921144246, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e5921144246, replyNumber=0, likeNumber=46, createdTime=2021-05-19, rootId=0, userName=ms24272190615788285182, userId=4e842500199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e5921144246, moduleTitle=JNCCN: 循环肿瘤DNA（ctDNA）应用于去势抵抗的转移性前列腺癌临床管理：多中心真实世界研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e5921144246)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395558, encodeId=71df139555863, content=<a href='/topic/show?id=7bbf93405a5' target=_blank style='color:#2F92EE;'>#转移性前列腺癌#</a>, objectTitle=Prostate Cancer P D：新诊断转移性前列腺癌放射治疗的长期结果, objectType=article, longId=210434, objectId=38a721043447, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38a721043447, replyNumber=0, likeNumber=43, createdTime=2021-04-26, rootId=0, userName=ms24272190615788285182, userId=4e842500199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38a721043447, moduleTitle=Prostate Cancer P D：新诊断转移性前列腺癌放射治疗的长期结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38a721043447)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395557, encodeId=674d139555e9e, content=<a href='/topic/show?id=7bbf93405a5' target=_blank style='color:#2F92EE;'>#转移性前列腺癌#</a>, objectTitle=Clin Cancer Res：镭223治疗增加转移性前列腺癌骨微环境中胞外囊泡的免疫检查点表达, objectType=article, longId=209757, objectId=bb26209e57ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb26209e57ad, replyNumber=0, likeNumber=41, createdTime=2021-04-11, rootId=0, userName=ms24272190615788285182, userId=4e842500199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb26209e57ad, moduleTitle=Clin Cancer Res：镭223治疗增加转移性前列腺癌骨微环境中胞外囊泡的免疫检查点表达, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb26209e57ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395556, encodeId=b7b51395556a8, content=<a href='/topic/show?id=7bbf93405a5' target=_blank style='color:#2F92EE;'>#转移性前列腺癌#</a>, objectTitle=Nat commun：数字化空间基因表达谱确定转移性前列腺癌的瘤间和瘤内异质性, objectType=article, longId=208104, objectId=3c0f208104c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c0f208104c6, replyNumber=0, likeNumber=42, createdTime=2021-03-09, rootId=0, userName=ms24272190615788285182, userId=4e842500199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c0f208104c6, moduleTitle=Nat commun：数字化空间基因表达谱确定转移性前列腺癌的瘤间和瘤内异质性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c0f208104c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395555, encodeId=261e1395555ff, content=<a href='/topic/show?id=7bbf93405a5' target=_blank style='color:#2F92EE;'>#转移性前列腺癌#</a>, objectTitle=Modra Pharmaceuticals于2021 ASCO GU年会公布其转移性前列腺癌IIb期临床试验初步数据, objectType=article, longId=207251, objectId=158620e25189, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=158620e25189, replyNumber=0, likeNumber=40, createdTime=2021-02-20, rootId=0, userName=ms24272190615788285182, userId=4e842500199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=158620e25189, moduleTitle=Modra Pharmaceuticals于2021 ASCO GU年会公布其转移性前列腺癌IIb期临床试验初步数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=158620e25189)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395554, encodeId=be481395554b1, content=<a href='/topic/show?id=7bbf93405a5' target=_blank style='color:#2F92EE;'>#转移性前列腺癌#</a>, objectTitle=Prostate Cancer P D：非转移性前列腺癌中局部治疗与根治性前列腺切除术的比较：倾向性评分匹配研究, objectType=article, longId=206746, objectId=ac1a206e46c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac1a206e46c9, replyNumber=0, likeNumber=41, createdTime=2021-02-05, rootId=0, userName=ms24272190615788285182, userId=4e842500199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac1a206e46c9, moduleTitle=Prostate Cancer P D：非转移性前列腺癌中局部治疗与根治性前列腺切除术的比较：倾向性评分匹配研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac1a206e46c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395553, encodeId=9cd91395553b1, content=<a href='/topic/show?id=7bbf93405a5' target=_blank style='color:#2F92EE;'>#转移性前列腺癌#</a>, objectTitle=JAMA Oncology：一种新可以更好地预测非转移性前列腺癌患者预后的新分期系统, objectType=article, longId=202517, objectId=e79120251eaf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e79120251eaf, replyNumber=0, likeNumber=41, createdTime=2020-10-27, rootId=0, userName=ms24272190615788285182, userId=4e842500199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e79120251eaf, moduleTitle=JAMA Oncology：一种新可以更好地预测非转移性前列腺癌患者预后的新分期系统, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e79120251eaf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395552, encodeId=1c7113955523b, content=<a href='/topic/show?id=7bbf93405a5' target=_blank style='color:#2F92EE;'>#转移性前列腺癌#</a>, objectTitle=J Clin Oncol：恩扎鲁胺治疗转移性前列腺癌时18氟化钠PET/CT和循环肿瘤细胞的时空变化, objectType=article, longId=200818, objectId=cdcb20081831, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdcb20081831, replyNumber=0, likeNumber=45, createdTime=2020-09-19, rootId=0, userName=ms24272190615788285182, userId=4e842500199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdcb20081831, moduleTitle=J Clin Oncol：恩扎鲁胺治疗转移性前列腺癌时18氟化钠PET/CT和循环肿瘤细胞的时空变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdcb20081831)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395551, encodeId=6a93139555178, content=<a href='/topic/show?id=7bbf93405a5' target=_blank style='color:#2F92EE;'>#转移性前列腺癌#</a>, objectTitle=NEJM：Nubeqa（darolutamide）显著延长非转移性前列腺癌患者的寿命！, objectType=article, longId=200507, objectId=259720050e88, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=259720050e88, replyNumber=0, likeNumber=34, createdTime=2020-09-12, rootId=0, userName=ms24272190615788285182, userId=4e842500199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=259720050e88, moduleTitle=NEJM：Nubeqa（darolutamide）显著延长非转移性前列腺癌患者的寿命！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=259720050e88)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

2020-05-29

498997979 (审核中...)

前往app查看评论内容

#转移性前列腺癌#

2023-07-29发表于江苏省

498997979 (审核中...)

前往app查看评论内容

#转移性前列腺癌# 学习了

2023-07-27发表于江苏省

ms24272190615788285182 (审核中...)

前往app查看评论内容

#转移性前列腺癌#

Eur Urol Oncol：雄激素剥夺疗法联合根治性局部治疗与单独的雄激素剥夺疗法治疗新诊断寡转移性前列腺癌的疗效比较

2022-07-18

ms24272190615788285182 (审核中...)

前往app查看评论内容

#转移性前列腺癌#

NEJM Evid：奥拉帕利联合阿比特龙治疗转移性前列腺癌结果公布（PROpel研究）

2022-06-16

ms24272190615788285182 (审核中...)

前往app查看评论内容

#转移性前列腺癌#

Eur Urol：非转移性前列腺癌患者中，高强度聚焦超声局部治疗后的癌症控制结果

2022-02-19

ms24272190615788285182 (审核中...)

前往app查看评论内容

#转移性前列腺癌#

BJU Int：根治性前列腺切除术治疗寡转移性前列腺癌的可行性和安全性评估

2022-01-20

ms24272190615788285182 (审核中...)

前往app查看评论内容

#转移性前列腺癌#

Front Oncol：化疗对转移性前列腺癌患者的总生存期影响

2021-12-01

ms24272190615788285182 (审核中...)

前往app查看评论内容

#转移性前列腺癌#

Front Oncol：基于SEER数据库比较前列腺癌根治术（PR）和放疗（RT）治疗转移性前列腺癌的生存结果

2021-11-29

ms24272190615788285182 (审核中...)

前往app查看评论内容

#转移性前列腺癌#

Lynparza联合阿比特龙治疗转移性前列腺癌，疗效积极

2021-09-28

ms24272190615788285182 (审核中...)

前往app查看评论内容

#转移性前列腺癌#

J Clin Oncol：前瞻性评估液体活检技术在针对不同耐药机制的转移性前列腺癌的临床预后作用

2021-07-05

ms24272190615788285182 (审核中...)

前往app查看评论内容

#转移性前列腺癌#

Eur Urol Focus：非转移性前列腺癌根治术后尿失禁的患者和肿瘤相关预后因素分析

2021-05-26

ms24272190615788285182 (审核中...)

前往app查看评论内容

#转移性前列腺癌#

JNCCN: 循环肿瘤DNA（ctDNA）应用于去势抵抗的转移性前列腺癌临床管理：多中心真实世界研究结果

2021-05-19

ms24272190615788285182 (审核中...)

前往app查看评论内容

#转移性前列腺癌#

Prostate Cancer P D：新诊断转移性前列腺癌放射治疗的长期结果

2021-04-26

ms24272190615788285182 (审核中...)

前往app查看评论内容

#转移性前列腺癌#

Clin Cancer Res：镭223治疗增加转移性前列腺癌骨微环境中胞外囊泡的免疫检查点表达

2021-04-11

ms24272190615788285182 (审核中...)

前往app查看评论内容

#转移性前列腺癌#

Nat commun：数字化空间基因表达谱确定转移性前列腺癌的瘤间和瘤内异质性

2021-03-09

ms24272190615788285182 (审核中...)

前往app查看评论内容

#转移性前列腺癌#

Modra Pharmaceuticals于2021 ASCO GU年会公布其转移性前列腺癌IIb期临床试验初步数据

2021-02-20

ms24272190615788285182 (审核中...)

前往app查看评论内容

#转移性前列腺癌#

Prostate Cancer P D：非转移性前列腺癌中局部治疗与根治性前列腺切除术的比较：倾向性评分匹配研究

2021-02-05

ms24272190615788285182 (审核中...)

前往app查看评论内容

#转移性前列腺癌#

JAMA Oncology：一种新可以更好地预测非转移性前列腺癌患者预后的新分期系统

2020-10-27

ms24272190615788285182 (审核中...)

前往app查看评论内容

#转移性前列腺癌#

J Clin Oncol：恩扎鲁胺治疗转移性前列腺癌时18氟化钠PET/CT和循环肿瘤细胞的时空变化

2020-09-19

ms24272190615788285182 (审核中...)

前往app查看评论内容

#转移性前列腺癌#

NEJM：Nubeqa（darolutamide）显著延长非转移性前列腺癌患者的寿命！

2020-09-12

科室
- - 订阅+
  - 更多科室
工具
服务